These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34172543)

  • 1. Developing a model to predict individualised treatment for gonorrhoea: a modelling study.
    Findlater L; Mohammed H; Gobin M; Fifer H; Ross J; Geffen Obregon O; Turner KME
    BMJ Open; 2021 Jun; 11(6):e042893. PubMed ID: 34172543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
    Riou J; Althaus CL; Allen H; Cole MJ; Grad YH; Heijne JCM; Unemo M; Low N
    BMC Infect Dis; 2023 Apr; 23(1):252. PubMed ID: 37081443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an association between previous infection with
    Allen H; Merrick R; Ivanov Z; Pitt R; Mohammed H; Sinka K; Hughes G; Fifer H; Cole MJ
    Sex Transm Infect; 2023 Feb; 99(1):1-6. PubMed ID: 35246477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of
    Blouin K; Lefebvre B; Trudelle A; Defay F; Perrault Sullivan G; Ezin Aloffan LND; Labbé AC
    BMJ Open; 2023 Aug; 13(8):e073849. PubMed ID: 37541749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
    Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N
    BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
    Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
    Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales.
    Town K; Obi C; Quaye N; Chisholm S; Hughes G;
    Sex Transm Infect; 2017 Feb; 93(1):39-45. PubMed ID: 27382010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.
    Cole MJ; Spiteri G; Jacobsson S; Pitt R; Grigorjev V; Unemo M;
    BMC Infect Dis; 2015 Aug; 15():321. PubMed ID: 26259560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance profiles of Neisseria gonorrhoeae isolates in Vienna, Austria: a phenotypic and genetic characterization from 2013 to 2020.
    Geusau A; Chromy D; Heissenberger D; Lippert K; Eder C; Heger F; Indra A; Willinger B; Pleininger S
    Int J Antimicrob Agents; 2022; 60(5-6):106656. PubMed ID: 35988663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
    Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
    Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can previous first-line therapies for Neisseria gonorrhoeae be targeted to specific patient subgroups to treat gonorrhea?
    Town K; Lowndes CM; Hughes G; Obi C; Chisholm S; Ison CA;
    Sex Transm Dis; 2015 Jan; 42(1):37-42. PubMed ID: 25504299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
    Sánchez-Busó L; Cole MJ; Spiteri G; Day M; Jacobsson S; Golparian D; Sajedi N; Yeats CA; Abudahab K; Underwood A; Bluemel B; Aanensen DM; Unemo M;
    Lancet Microbe; 2022 Jun; 3(6):e452-e463. PubMed ID: 35659907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys.
    Clifton S; Bolt H; Mohammed H; Town K; Furegato M; Cole M; Campbell O; Fifer H; Hughes G
    J Antimicrob Chemother; 2018 Apr; 73(4):923-932. PubMed ID: 29394396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.